Literature DB >> 30158257

Acute spontaneous intracranial epidural haematoma and disseminated intravascular coagulation in a paediatric sickle cell patient.

Christopher Banerjee1, June Yowtak1, Diana Fridlyand2, Cargill Alleyne1.   

Abstract

An African American teenage boy during an acute sickle cell crisis spontaneously developed acute bifrontal epidural haematomas (EDHs) in addition to disseminated intravascular coagulation (DIC). The successfully evacuated EDH reaccumulated postoperatively. After multiple transfusions, the patient underwent repeat surgery. Subsequent maximal medical therapy was unable to significantly improve the patient's neurological status, and due to family wishes, care was withdrawn. EDH are the most common emergent neurosurgical complication of sickle cell disease (SCD). Twenty-two such cases have been previously reported. We present one further complicated by DIC leading to reaccumulation of the patient's EDH. An understanding of the mechanisms of EDH formation in SCD and their associated radiological findings could help clinicians identify when a patient is at high risk of EDH formation and thus offer the potential for early intervention prior to the development of an emergency. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  neuroimaging; neurosurgery; sickle cell disease

Mesh:

Year:  2018        PMID: 30158257     DOI: 10.1136/bcr-2018-224504

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Spontaneous Epidural Hematoma in Sickle Cell Crisis: A Case Report.

Authors:  Jiss Joy; Maria A Vasnaik; Vivek Bhat; Seetharam Anandram; Arun George
Journal:  Cureus       Date:  2022-04-26

2.  Azithromycin Reduces Markers of Vascular Damage in Pediatric Patients With Sickle Cell Disease.

Authors:  Peter N Uchakin; Vishwas S Sakhalkar; Francis C Dane; Olga N Uchakina; Jatayah N Sheed; William T Uphouse; Om V Sakhalkar
Journal:  J Hematol       Date:  2021-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.